COVID-19 linked to lower subsequent risk of type 1 diabetes
New research to be presented at the Annual Meeting of The European Association for the Study of Diabetes…
Landmark study identifies new genetic risk factors linked to fibromyalgia syndrome
In a landmark study published in Nature Medicine, an international team of researchers has identified new genetic risk…
Ultrasensitive Blood Test Detects Sjögren’s Disease Years Early, Study Finds
An ultrasensitive blood test could detect Sjögren’s disease more than a decade before a clinical diagnosis, according to…
Immune cells drive abnormal joint tissue growth in rheumatoid arthritis
Researchers at Hospital for Special Surgery (HSS) have identified a specialized population of immune cells that play a…
GLP-1 medicines may cut clot-related risks in chronically inflamed patients
A large real-world analysis suggests GLP-1 receptor agonists may offer clot-related and survival benefits in a chronically inflamed,…
GLP-1-based meds linked to fewer heart events in adults with obesity, autoimmune disease
Research Highlights:
Among people with both obesity and an autoimmune disease, those taking GLP-1-based medications had fewer…
Study reveals why women face higher autoimmune disease risks
Ahead of World Lupus Day on May 10, new research from the Garvan Institute of Medical Research and…
What’s the Next Big Thing After GLP-1 Drugs? CRISPR Therapeutics May Have the Answer.
Investors are always on the lookout for the next revolutionary technology or product. In recent times, this has…
A Doctor Diagnosed At 17 Is Now Redesigning Preventive Care For Women
Dr. Léger’s new Women’s Health Program at Extension Health hopes to rewrite women’s health. Extension Health “Your Labs…
Study reveals immune aging differs significantly between men and women
Statistics show clear differences in the population’s immune system according to sex: men are more susceptible to infections…
CFHR1 could be a new diagnostic marker for IgA nephropathy
Immunoglobulin A (IgA) nephropathy is an autoimmune disease characterized by the deposition of circulating IgA-containing immune complexes (IgA-ICs)…
Immune scaffold predicts onset weeks early
A retrievable immune scaffold reveals a 5–7 week presymptomatic window for tracking type 1 diabetes progression, long before…